Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype
This study is ongoing, but not recruiting participants.
Study NCT00001572   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: August 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
B Cell Lymphoma
Follicular Lymphoma
Neoplasm
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell
Lymphoma, Follicular
Neoplasms
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Interventions listed in this trial
Id-KLH Vaccine
QS-21 (Stimulation-QS-21) Drug
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulin Idiotypes
Immunoglobulins
QS 21
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services